Sézary syndrome Images
Go to article Sézary syndrome
Sézary syndrome.
Sézary syndrome: extensive, less characteristic, scaly and massively itching and painful erythroderma in an 81-year-old patient.
Sézary syndrome: 62-year-old patient. 1 year ago first skin changes with uncharacteristic moderately itchy erythema on the trunk and extremities. Findings: Erythroderma with extensive edematous swelling of the skin; massive pruritus; taut lower legs; massive lymph node packages of the groin.
Sézary syndrome: universal redness with generalized lymphadenopathy; massive itching combined with pain when the integument dries out.
Sézary syndrome: universal redness with small lamellar scaling, massive itching, pain at times.
Sézary syndrome: universal redness with small lamellar scaling, massive itching, pain at times.
Sézary syndrome: universal redness with small bizarre recesses. small spotted scaling. massive itching, sometimes pain.
Sézary syndrome: universal redness with small lamellar scaling, massive itching, pain at times.
Differential diagnosis "Sezary syndrome" : non "leukemic" erythrodermic form of mycosis fungoides.
Sézary Syndrome: universal redness with small-focus recesses. small spotted scaling. massive itching, pain at times. here detailed picture of the right arm
Sézary-Syndrome. pat. as above. symmetric, flat, hyperkeratosis at the same time with development of erythroderma
Sézary syndrome: flat, moderate hyperkeratosis of the palm of the hand, patient with erythroderma.
Sézary syndrome: transverse white bands and discrete leukonychia in existing erythroderma.
Sézary syndrome: detailed picture of the groin region with recognizable lymphadeopathy.
Sézary syndrome: severe final febrile developmental stage. universal redness of the skin with extensive skin detachment. generalized lymphadenopathy, leukemic lymphocytic (CD4+) blood count (75-year-old female patient.
Sézary-Syndrome. pat. as above. symmetric, flat, hyperkeratosis at the same time with development of erythroderma
Sézary syndrome. further analysis of the CD4 cells of the same patient. anti-CD3, anti-CD4 and anti-CD7/anti-CD26 antibodies were used. In this patient, mainly helper cells are found which have the marker recognition CD4+ CD7- and CD4+ CD26- respectively. These populations most likely correspond to the leukemic fraction. These cells also show a decreased CD4 expression (population shifted to the left).
